
{
    "credit": [
        {
            "email": "zyp19871208@126.com",
            "name": "Yunpeng Zhang",
            "typeEntity": "Person",
            "typeRoles": [
            ]
        },
        {
            "email": "liangcheng@hrbmu.edu.cn",
            "name": "Liang Cheng",
            "typeEntity": "Person",
            "typeRoles": [
            ]
        },
        {
            "email": "hanjunwei1981@163.com",
            "name": "Junwei Han",
            "typeEntity": "Person",
            "typeRoles": [
            ]
        }
    ],
    "function": [
        {
            "operation": [
                {
                    "term": "Differential gene expression analysis",
                    "uri": "http://edamontology.org/operation_3223"
                },
                {
                    "term": "Gene-set enrichment analysis",
                    "uri": "http://edamontology.org/operation_2436"
                }
            ]
        }
    ],
    "labels": {
        "language": [
            "R"
        ],
        "license": "GPL-2.0",
        "topic": [
            {
                "term": "Drug metabolism",
                "uri": "http://edamontology.org/topic_3375"
            },
            {
                "term": "Drug discovery",
                "uri": "http://edamontology.org/topic_3336"
            },
            {
                "term": "Preclinical and clinical studies",
                "uri": "http://edamontology.org/topic_3379"
            }
        ]
    },
    "publication": [
        {
            "doi": "10.1002/1878-0261.12564",
            "pmcid": "PMC6763777",
            "pmid": "31408580"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:PriorCD",
        "biotoolsID": "PriorCD",
        "description": "Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities | Prioritizing Cancer Drugs for Interested Cancer | Prioritize candidate cancer drugs for drug repositioning based on the random walk with restart algorithm in a drug-drug functional similarity network. 1) We firstly constructed a drug-drug functional similarity network by integrating pathway activity and drug activity derived from the NCI-60 cancer cell lines. 2) Secondly, we calculated drug repurposing score according to a set of approved therapeutic drugs of interested cancer based on the random walk with restart algorithm in the drug-drug functional similarity network. 3) Finally, the permutation test was used to calculate the statistical significance level for the drug repurposing score",
        "homepage": "https://cran.r-project.org/web/packages/PriorCD",
        "name": "PriorCD"
    }
}